Immediate Impact
2 by Nobel laureates 24 from Science/Nature 69 standout
Citing Papers
Covalent targeted radioligands potentiate radionuclide therapy
2024 StandoutNature
Natural killer cell therapies
2024 StandoutNature
Works of Frank Hartmann being referenced
Anti-CD16/CD30 bispecific antibody treatment for Hodgkin's disease: role of infusion schedule and costimulation with cytokines.
2001
Treatment of Refractory Hodgkin's Disease With an Anti-CD16/CD30 Bispecific Antibody
1997
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Frank Hartmann | 611 | 925 | 884 | 77 | 2.7k | |
| Roberto Giardini | 369 | 1702 | 1172 | 85 | 3.2k | |
| Αthanasios Fassas | 198 | 1182 | 648 | 62 | 2.6k | |
| Arun Balakumaran | 368 | 1184 | 2634 | 78 | 3.6k | |
| A Kurata | 1589 | 493 | 513 | 71 | 4.3k | |
| Andreas Schirbel | 581 | 258 | 1368 | 102 | 2.9k | |
| Ingrid Simonitsch‐Klupp | 182 | 1045 | 568 | 92 | 2.3k | |
| Stefan Wöhrer | 284 | 978 | 668 | 45 | 2.4k | |
| Yasufumi Masaki | 652 | 693 | 782 | 114 | 2.5k | |
| Judith Dierlamm | 454 | 1793 | 1255 | 109 | 4.0k | |
| Luís Teixeira | 347 | 510 | 1034 | 91 | 3.2k |
All Works
Login with ORCID to disown or claim papers
Loading papers...